Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03147118 · ClinicalTrials.gov registry record
Evaluating Palpation Guided Injections in Trapeziometacarpal Arthritis
A clinical trial, sponsored by Prisma Health-Upstate.
- Completed
- Registry status
- 37
- Enrollment target
NCT03147118: Completed study, sponsored by Prisma Health-Upstate.
NCT03147118 is a clinical trial that has completed, run by Prisma Health-Upstate. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03147118 has completed, sponsored by Prisma Health-Upstate.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the accuracy of trapeziometacarpal injections using palpation alone. The importance of this study is one of education, cost containment, and decreased risk to the patient. If it can be shown that the accuracy of trapeziometacarpal injections using palpation alone is similar to the reported accuracy of ultrasound and fluoroscopy, then these guided techniques may not be needed.
Primary Outcome
Accuracy judged in a blinded fashion, rated injection in joint or out of joint
Interventions
- DIAGNOSTIC_TEST Arthrogram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2017-09-15 |
What the finished NCT03147118 record still lists
NCT03147118 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Arthrogram is the first listed.
NCT03147118 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03147118 about?
NCT03147118 is a clinical study titled "Evaluating Palpation Guided Injections in Trapeziometacarpal Arthritis". The objective of this study is to evaluate the accuracy of trapeziometacarpal injections using palpation alone. The importance of this study is one of education, cost containment, and decreased risk to the patient. If it can be shown that the accuracy of trapeziometacarpal injections using palpation...
What is the current status of trial NCT03147118?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2017-05-01. Estimated completion is 2017-09-15.
What interventions are being tested in trial NCT03147118?
The interventions under investigation include: Arthrogram (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03147118?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI